Abstract in proceedings of the Fourth International Congress of CiiEM: Health, Well-Being and Ageing in the 21st Century, held at Egas Moniz’ University Campus in Monte de Caparica, Almada, from 3–5 June 2019.This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.info:eu-repo/semantics/publishedVersio
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with the progressive loss of moto...
Sporadic Amyotrophic lateral sclerosis (sALS) is a complex, invariably fatal, disease with a poorly ...
BackgroundAmyotrophic lateral sclerosis (ALS) is a multifactorial fatal motoneuron disease without a...
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that has no effective treat...
Abstract in proceedings of the Fourth International Congress of CiiEM: Health, Well-Being and Ageing...
The last 30 years have seen a major advance in the understanding of the clinical and pathological he...
Purpose of review This review draws together the most recent findings in ALS biomarker research ...
© IOS Press and the authors. All rights reservedINTRODUCTION: Amyotrophic Lateral Sclerosis (ALS) i...
The main reason for short survival in amyotrophic lateral sclerosis (ALS) is involvement of respirat...
Amyotrophic lateral sclerosis (ALS) belongs to the group of motor neuron diseases, in which the dege...
© 2020 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LL...
Since amyotrophic lateral sclerosis (ALS) was discovered and described in 1869 as a neurodegenerativ...
The last 30 years have seen a major advance in the understanding of the clinical and pathological he...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
© 2019 Published by Elsevier B.V.Background: IL-6 is an inflammatory cytokine that is a possible fac...
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with the progressive loss of moto...
Sporadic Amyotrophic lateral sclerosis (sALS) is a complex, invariably fatal, disease with a poorly ...
BackgroundAmyotrophic lateral sclerosis (ALS) is a multifactorial fatal motoneuron disease without a...
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that has no effective treat...
Abstract in proceedings of the Fourth International Congress of CiiEM: Health, Well-Being and Ageing...
The last 30 years have seen a major advance in the understanding of the clinical and pathological he...
Purpose of review This review draws together the most recent findings in ALS biomarker research ...
© IOS Press and the authors. All rights reservedINTRODUCTION: Amyotrophic Lateral Sclerosis (ALS) i...
The main reason for short survival in amyotrophic lateral sclerosis (ALS) is involvement of respirat...
Amyotrophic lateral sclerosis (ALS) belongs to the group of motor neuron diseases, in which the dege...
© 2020 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LL...
Since amyotrophic lateral sclerosis (ALS) was discovered and described in 1869 as a neurodegenerativ...
The last 30 years have seen a major advance in the understanding of the clinical and pathological he...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
© 2019 Published by Elsevier B.V.Background: IL-6 is an inflammatory cytokine that is a possible fac...
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with the progressive loss of moto...
Sporadic Amyotrophic lateral sclerosis (sALS) is a complex, invariably fatal, disease with a poorly ...
BackgroundAmyotrophic lateral sclerosis (ALS) is a multifactorial fatal motoneuron disease without a...